Trial intelligence / Profile preview

Nitric Oxide for Pediatric ARDS

NCT00240487Phase 3Completed

Sponsor
Children's Hospital of Philadelphia
Start
Sep 2000
Primary completion
Sep 2008
Modality
DNA Intercalators/Alkylators, Inhalation Devices
Countries
1
01

Overview

A Phase 3 trial of nitric oxide in acute respiratory distress syndrome (ARDS), sponsored by Children's Hospital of Philadelphia. Started Sep 2000; status: completed.

02

Drugs

nitric oxide
03

Conditions

acute respiratory distress syndrome (ARDS)

Beyond the preview

Go deeper on NCT00240487.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00240487.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call